After months of melodrama and acrimonious exchanges between Jim Cornelius and Carl Icahn, Eli Lilly, not Bristol-Myers Squibb, will acquire ImClone and gain access to the multibillion dollar Erbitux
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The ink hasn’t had time to try on the deal sheet and Pfizer already has announced what the impact of its acquisition of Wyeth will have on the combined company. Here’s what to expect: Pfizer will sh
read more » Discuss Add this link to...Bury Add to:
| Bookmarks